58 related articles for article (PubMed ID: 4001287)
1. Prevalence of medication treatment for hyperactive adolescents.
Safer DJ; Krager JM
Psychopharmacol Bull; 1985; 21(2):212-5. PubMed ID: 4001287
[No Abstract] [Full Text] [Related]
2. Trends in the prevalence of chronic medication use in children: 2002-2005.
Cox ER; Halloran DR; Homan SM; Welliver S; Mager DE
Pediatrics; 2008 Nov; 122(5):e1053-61. PubMed ID: 18977954
[TBL] [Abstract][Full Text] [Related]
3. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
Waring ME; Lapane KL
Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
[TBL] [Abstract][Full Text] [Related]
4. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
Visser SN; Lesesne CA; Perou R
Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
[TBL] [Abstract][Full Text] [Related]
5. Increased methylphenidate usage for attention deficit disorder in the 1990s.
Safer DJ; Zito JM; Fine EM
Pediatrics; 1996 Dec; 98(6 Pt 1):1084-8. PubMed ID: 8951257
[TBL] [Abstract][Full Text] [Related]
6. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric comorbidity differences in clinic-referred children and adolescents with ADHD according to the subtypes and gender.
Ghanizadeh A
J Child Neurol; 2009 Jun; 24(6):679-84. PubMed ID: 19491114
[TBL] [Abstract][Full Text] [Related]
8. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
[TBL] [Abstract][Full Text] [Related]
9. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
[TBL] [Abstract][Full Text] [Related]
10. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder.
Ibrahim el SR
Hum Psychopharmacol; 2002 Jul; 17(5):225-31. PubMed ID: 12404679
[TBL] [Abstract][Full Text] [Related]
11. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
Biederman J; Pliszka SR
J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
[TBL] [Abstract][Full Text] [Related]
12. [Confirmation of the high prevalence of attention deficit disorder in a Colombian community].
Pineda DA; Lopera F; Henao GC; Palacio JD; Castellanos FX;
Rev Neurol; 2001 Feb 1-15; 32(3):217-22. PubMed ID: 11310271
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy and behaviour therapy--competition or cooperation?
van Engeland H
Acta Paedopsychiatr; 1993; 56(2):123-7. PubMed ID: 8135110
[TBL] [Abstract][Full Text] [Related]
14. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
Gadow KD; Sverd J
Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
[No Abstract] [Full Text] [Related]
15. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
16. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
17. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
18. Stimulant medication and the hyperactive adolescent: myths and facts.
Clampit MK; Pirkle JB
Adolescence; 1983; 18(72):811-22. PubMed ID: 6666706
[TBL] [Abstract][Full Text] [Related]
19. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate patterns among Medicaid youths.
Zito JM; Safer DJ; dosReis S; Magder LS; Riddle MA
Psychopharmacol Bull; 1997; 33(1):143-7. PubMed ID: 9133766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
